Elucidating the immunological effects of 5-azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma

Medicin og biovidenskab

• Azacitidine 100%
• T-Lymphocyte Epitopes 90%
• Myelodysplastic Syndromes 84%
• HLA Antigens 77%
• Melanoma 62%
• Ligands 53%
• T-Lymphocytes 38%
• Histocompatibility 20%
• Testicular Neoplasms 19%
• Peptides 15%
• Antigens 15%
• Therapeutics 12%
• Neoplasms 10%
• Monophenol Monooxygenase 10%
• MAGE-A10 antigen 9%
• varespladib methyl 8%
• Nodal Protein 7%
• Flow Cytometry 6%
• Melanoma-Specific Antigens 5%
• Epitope Mapping 5%
• Pharmaceutical Preparations 5%
• Clinical Trials, Phase I 5%
• Demethylation 5%
• Histocompatibility Antigens Class I 4%
• K562 Cells 4%
• Population 4%
• North America 4%
• Allergy and Immunology 4%
• Ultraviolet Rays 4%
• Tumor Suppressor Genes 4%
• Genetic Promoter Regions 4%
• Blood Cells 3%
• Vaccination 3%
• Immune System 3%
• Tissue Donors 3%
• Proteins 3%
• Enzyme-Linked Immunosorbent Assay 2%
• Amino Acids 2%
• Staining and Labeling 2%
• Genes 1%